From February 5, 2024 to March 31, 2024, the company has repurchased 10,018,000 shares, representing 2.09% for CNY 148.61 million. With this, the company has completed the repurchase of 10,018,000 shares, representing 2.09% for CNY 148.61 million under the buyback announced on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.17 CNY | -3.47% |
|
-2.48% | -17.81% |
Jun. 14 | Foyou Pharma Gets China Approval for Parkinson's Disease Drug | MT |
May. 23 | Foyou Pharmaceutical Gets Nod to Market Valproic Acid | MT |
1st Jan change | Capi. | |
---|---|---|
-17.81% | 918M | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- 601089 Stock
- News Beijing Foyou Pharma CO.,LTD
- Tranche Update on Beijing Foyou Pharma CO.,LTD's Equity Buyback Plan announced on February 6, 2024.